Comparison of Drug Resistance of Bile Isolated Bacteria in Nanjing from 2017 to 2020

Chu Chu¹ and Hong-Mei Ding^1,

¹Department of Laboratory Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

Cite this paper

Chu Chu and Hong-Mei Ding. Comparison of Drug Resistance of Bile Isolated Bacteria in Nanjing from 2017 to 2020. American Journal of Clinical Medicine Research. 2022; 10(1):1-5. doi: 10.12691/AJCMR-10-1-1

Abstract

Background: Analyzed pathogenic bacteria isolated from bile samples of patients with biliary tract infection and their drug resistance in the first Affiliated Hospital of Nanjing Medical University from 2017 to 2020, so as to provide evidence for the treatment of biliary tract infection. Methods: Clinical strains isolated from bile specimens of patients suspected of biliary infection in the First Affiliated Hospital of Nanjing Medical University from 2017 to 2020 were collected, The drug susceptibility criteria are based on the standards published by the National Standardization Committee of the US Clinical Laboratories. WHONET 5.6 software was used to analyze the distribution of pathogens and drug resistance. Results: From January 2017 to December 2020, a total of 2006 strains of bile pathogenic bacteria were cultured and identified. There were 1253 cases of gram-negative bacilli, 638 cases of gram-positive cocci, 98 cases of fungi, and 17 cases of Gram-positive bacilli. The top five pathogens of Gram negative bacilli were Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Pseudomonas aeruginosa, Acinetobacter baumannii. The top five pathogens of gram positive cocci were Enterococcus faecium, Enterococcus faecalis, Enterococcus gallinarum, Enterococcus faecalis and Staphylococcus epidermidis. the resistance rate of Escherichia coli to ampicillin, ampicillin / sulbactam, cefotetan, ceftazidime, ceftriaxone,cefepime, itronam, compound trimethoprim decreased, the resistance rate of Klebsiella pneumoniae to gentamicin, levofloxacin decreased, the resistance rate of Enterobacter cloacae to ciprofloxacin, levofloxacin decreased. the resistance rate of Pseudomonas aeruginosa to ceftazidime, cefepime, gentamicin decreased. the resistance rate of Acinetobacter baumannii to ceftazidime, ciprofloxacin decreased. the resistance rate of Enterococcus faecium to penicillin G, high concentration streptomycin, erythromycin decreased. Conclusions: Enterogenic pathogens were the main pathogens in China. Such as Escherichia coli, Klebsiella pneumoniae, Enterococcus faecalis and Enterococcus faecalis; Nosocomial infection pathogens. For example, Pseudomonas aeruginosa and Acinetobacter also need to be paid attention to. Clinicians should improve their awareness of microbiological examination and provide more reliable pathogenic evidence for the selection of clinical antibiotic.

Keywords

Biliary tract infection, pathogenic bacteria, drug resistance, Nanjing

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Keishi Sugimachi, Tomohiro Iguchi, Yohei Mano, etal. Significance of bile culture surveillance for postoperative management of pancreatoduodenectomy, World J Surg Oncol, 2019, 17(1): 232.
[2]	Ji Won Park, Jong Kyun Lee, Kyu Taek Lee, etal. How to interpret the bile culture results of patients with biliary tract infections, Clin Res Hepatol Gastroenterol, 2014, 38(3): 300-309.
[3]	Xue-Xiang Gu, Meng-Pei Zhang, Yan-Feng Zhao, etal. Clinical and microbiological characteristics of patients with biliary disease, World J Gastroenterol, 2020, 26(14): 1638-1646.
[4]	Chengli Wang, Haipeng Yu, Ji'an He, etal. Comparative analysis of bile culture and blood culture in patients with malignant biliary obstruction complicated with biliary infection, J Cancer Res Ther, 2021, 17(3): 726-732.
[5]	Rajan Kochar, Subhas Banerjee. Infections of the biliary tract, Gastrointest Endosc Clin N Am, 2013, 23(2): 199-218.
[6]	Brandy R Lu, Cara L Mack. Inflammation and biliary tract injury, Curr Opin Gastroenterol, 2009, 25(3): 260-4.
[7]	Jijun Zhao, Qin Wang, Jianhua Zhang. Changes in Microbial Profiles and Antibiotic Resistance Patterns in Patients with Biliary Tract Infection over a Six-Year Period, Surg Infect (Larchmt), 2019, 20(6): 480-485.
[8]	Z Y Wu, X S Wu, W Y Yao, etal. Pathogens' distribution and changes of antimicrobial resistance in the bile of acute biliary tract infection patients, Zhonghua Wai Ke Za Zhi, 59(1):24-31.
[9]	A Tanaka, P S C Leung, M E Gershwin. Pathogen infections and primary biliary cholangitis, Clin Exp Immunol, 2019, 195(1): 25-34.
[10]	Christian van Delden. Bacterial biliary tract infections in liver transplant recipients, Curr Opin Organ Transplant, 2014, 19(3): 223-8.